Back to first-pass browser

First-pass extracted concept

cell-free biosensors

Candidate: concept label2 source documents5 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

CFBs

Extracted Explainers

What the tool is doing

Cell-free biosensors are presented as a platform for instant, on-demand biomolecular detection. The abstract frames them as an interface between digital and biomolecular systems within synthetic biology.

Source 1DOIPubMed

Cell-free biosensors convert target metabolite concentrations into observable outputs in a system that is independent of cell growth. The abstract presents them as contributors to microbial biosynthesis optimization through a distinct approach.

Source 2DOIPubMed

Resources required

They function using transcription-translation machinery. The abstract does not provide further implementation details.

Source 2DOIPubMed

What problem it solves

The abstract states that CFBs overcome limitations inherent in traditional cell-based sensors. They are positioned as useful for diagnostics and other frontier applications.

Source 1DOIPubMed

They help metabolic engineers assess microbial production more efficiently when pathway design, optimization, and evaluation are otherwise time- and labor-intensive.

Source 2DOIPubMed

Alternatives

The abstract explicitly contrasts cell-free biosensors with traditional cell-based sensors.

Source 1DOIPubMed

The abstract contrasts cell-free biosensors with whole-cell biosensors that operate within living microorganisms.

Source 2DOIPubMed

Evidence Snippets

cell-free biosensors (CFBs) leverage core advantages—including rapid prototyping, high controllability, excellent biosafety, and tolerance to potentially toxic substances
Evidence 1Source 1DOIPubMedprovenance
cell-free biosensors, which function independently of cell growth using transcription-translation machinery
Evidence 2Source 2DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1advantage statementsupports2026Source 1DOIPubMed

Cell-free biosensors offer rapid prototyping, high controllability, biosafety, and tolerance to potentially toxic substances.

Quoted textsource-backed
cell-free biosensors (CFBs) leverage core advantages—including rapid prototyping, high controllability, excellent biosafety, and tolerance to potentially toxic substances
Claim 2application scopesupports2026Source 1DOIPubMed

Cell-free biosensors have broad application potential in biological circuit design, metabolic pathway optimization, and in vitro diagnostics.

Quoted textsource-backed
These fields encompass the precise design of biological circuits, intelligent optimization of metabolic pathways, and efficient in vitro diagnostics.
Claim 3comparative platform claimsupports2026Source 1DOIPubMed

Cell-free biosensors overcome limitations of traditional cell-based sensors and provide a platform for instant, on-demand biomolecular detection.

Quoted textsource-backed
CFBs overcomes limitations inherent in traditional cell-based sensors, offering a powerful platform for instant, on-demand biomolecular detection.
Claim 4application statementsupports2025Source 2DOIPubMed

Whole-cell and cell-free biosensors have contributed to microbial biosynthesis optimization through distinct approaches.

Claim 5definitionsupports2025Source 2DOIPubMed

Cell-free biosensors function independently of cell growth using transcription-translation machinery.